These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 10068105)
1. Course of platelet counts in cirrhotic patients after implantation of a transjugular intrahepatic portosystemic shunt--a prospective, controlled study. Gschwantler M; Vavrik J; Gebauer A; Kriwanek S; Schrutka-Kölbl C; Fleischer J; Madani B; Brownstone E; Tscholakoff D; Weiss W J Hepatol; 1999 Feb; 30(2):254-9. PubMed ID: 10068105 [TBL] [Abstract][Full Text] [Related]
2. Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis. Karasu Z; Gurakar A; Kerwin B; Hulagu S; Jazzar A; McFadden R; Nour B; Sebastian A; Cassidy F; Stokes K; Van Thiel DH; Wright H Dig Dis Sci; 2000 Oct; 45(10):1971-6. PubMed ID: 11117569 [TBL] [Abstract][Full Text] [Related]
3. [Changes in hematologic and hemostatic parameters after transjugular intrahepatic portosystemic shunt (TIPS) implantation]. Papp M; Mezei G; Udvardy M; Altorjay I Orv Hetil; 2003 Jul; 144(27):1341-5. PubMed ID: 12908147 [TBL] [Abstract][Full Text] [Related]
4. Coated transjugular intrahepatic portosystemic shunt does not improve thrombocytopenia in patients with liver cirrhosis. Barney EJ; Little EC; Gerkin RD; Ramos AX; Kahn J; Wong M; Kolli G; Manch R Dig Dis Sci; 2012 Sep; 57(9):2430-7. PubMed ID: 22588242 [TBL] [Abstract][Full Text] [Related]
6. Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Alvarez OA; Lopera GA; Patel V; Encarnacion CE; Palmaz JC; Lee M Am J Gastroenterol; 1996 Jan; 91(1):134-7. PubMed ID: 8561113 [TBL] [Abstract][Full Text] [Related]
7. The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis. Massoud OI; Zein NN Gastroenterol Hepatol (N Y); 2017 May; 13(5):286-291. PubMed ID: 28656025 [TBL] [Abstract][Full Text] [Related]
8. Systemic and splanchnic endothelin-1 plasma levels in liver cirrhosis before and after transjugular intrahepatic portosystemic shunt (TIPS). Nolte W; Ehrenreich H; Wiltfang J; Pahl K; Unterberg K; Kamrowski-Kruck H; Schindler CG; Figulla HR; Buchwald AB; Hartmann H; Ramadori G Liver; 2000 Feb; 20(1):60-5. PubMed ID: 10726962 [TBL] [Abstract][Full Text] [Related]
9. Brain regional homogeneity changes following transjugular intrahepatic portosystemic shunt in cirrhotic patients support cerebral adaptability theory--a resting-state functional MRI study. Ni L; Qi R; Zhang LJ; Zhong J; Zheng G; Wu X; Fan X; Lu GM Eur J Radiol; 2014 Mar; 83(3):578-83. PubMed ID: 24299611 [TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment. Teng D; Zuo H; Liu L; Dong J; Ding L Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813 [TBL] [Abstract][Full Text] [Related]
11. Time-Harmonic Elastography of the Liver is Sensitive to Intrahepatic Pressure Gradient and Liver Decompression after Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation. Tzschätzsch H; Sack I; Marticorena Garcia SR; Ipek-Ugay S; Braun J; Hamm B; Althoff CE Ultrasound Med Biol; 2017 Mar; 43(3):595-600. PubMed ID: 27979668 [TBL] [Abstract][Full Text] [Related]
12. Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis. Lawrence SP; Lezotte DC; Durham JD; Kumpe DA; Everson GT; Bilir BM Dig Dis Sci; 1995 Jul; 40(7):1575-80. PubMed ID: 7628285 [TBL] [Abstract][Full Text] [Related]
13. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397 [TBL] [Abstract][Full Text] [Related]
14. Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients. Su AP; Cao SS; Le Tian B; Da Zhang Z; Hu WM; Zhang Y; Wang ZL; Babu SR; Hu T Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):53-9. PubMed ID: 22099870 [TBL] [Abstract][Full Text] [Related]